The NHS has provided guidance on identifying flu symptoms, which can emerge very rapidly and include a sudden high ...
The main market opportunities in the RSV prophylaxis field lie in the development of new monoclonal antibodies and vaccines, with substantial growth expected due to late-stage pipeline products. This ...
If RSV develops into a more serious infection such as pneumonia or bronchiolitis, it may also cause a worsening cough, ...
Since the launch of its first nebulizer in 1978, OMRON Healthcare has pioneered the development of compact home-use devices that deliver medical-grade respiratory treatment outside of clinical ...
Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a comprehensive strategic collaboration agreement covering joint project development, exclusive ...
CANDELA Reybauld has spent her whole life breathing through a partially blocked nostril. The mum-of-two was left stunned ...
A new study published in the journal of Arthritis & Rheumatology revealed that patients with rheumatoid arthritis-associated ...
As cold weather sets in, viruses such as influenza, RSV, and COVID-19 are resurfacing. Quickly identifying symptomatic individuals is an essential part of any strategy to fight their spread. Yet, ...
Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...